TBXU Performance — Direxion Daily Biotech Top 5 Bull 2X ETF

Data updated: 2026-09-28

In the 12 months to Jul 2026 the fund took in a net $1.4M, and assets reached $2.57M.

TBXU Growth of $100

What $100 invested in Direxion Daily Biotech Top 5 Bull 2X ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.

PeriodTBXUCategory average
Since data start (Sep 2025 – Jul 2026)$140$98

TBXU Trailing Returns

Total returns to Jul 2026, from SEC N-PORT.

PeriodTotal return
YTD+11.20%

TBXU Annual Returns

Calendar-year total returns of Direxion Daily Biotech Top 5 Bull 2X ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jul)+11.20%
2025 (Sep–Dec)+25.74%

TBXU Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+7.0%+8.5%−12.6%−5.9%−0.6%+9.9%+6.6%—————
2025————————0.0%+15.0%+17.5%−6.9%

TBXU Risk

Risk measures from monthly returns over Sep 2025 – Jul 2026.

  • Best month: +17.51% (Nov 2025)
  • Worst month: −12.60% (Mar 2026)

TBXU Fund Flows

Monthly money in and out of Direxion Daily Biotech Top 5 Bull 2X ETF, from SEC Form N-PORT.

  • 12-month net flow: $1.4M
  • 12-month gross sales (incl. reinvestments): $4.0M
  • Sales ÷ redemptions: 1.57×
MonthSalesRedemptionsNet flow
Jul 2026$0$873K−$873K
Jun 2026$0$0$0
May 2026$0$0$0
Apr 2026$0$0$0
Mar 2026$0$0$0
Feb 2026$0$870K−$870K
Jan 2026$0$0$0
Dec 2025$813K$0$813K
Nov 2025$0$792K−$792K
Oct 2025$668K$0$668K
Sep 2025$2.5M$0$2.5M

TBXU Assets Under Management

Net assets of Direxion Daily Biotech Top 5 Bull 2X ETF by report date, from SEC N-PORT filings.

Report dateNet assets
2026-07-31$2.57M
2026-04-30$2.95M
2026-01-31$4.15M
2025-10-31$3.59M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.